Crossmark

Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-023-07884-y

Published Online: 2024-01-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Jing

Doan, Lisa V. http://orcid.org/0000-0002-7833-1753
Axelrod, Deborah

Rotrosen, John

Wang, Binhuan

Park, Hyung G.

Edwards, Robert R.

Curatolo, Michele

Jackman, Carina

Perez, Raven

,
Funding

Funding for this research was provided by:

National Cancer Institute (UH3CA261067)

National Center for Advancing Translational Sciences (U24TR001608-05S3, U24TR001597-06S1, U24TR001579-06S1, U24TR001609)
License Information

Text and Data Mining valid from 2024-01-19

Version of Record valid from 2024-01-19
More Information

Article History

Received: 5 October 2023

Accepted: 15 December 2023

First Online: 19 January 2024

Declarations

:

: The study was initially approved on October 29, 2021, by the University of Utah Institutional Review Board. Version 4 of the protocol was approved on June 29, 2023. Written, informed consent to participate will be obtained from all participants.

: Available upon reasonable request.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below